Travere Therapeutics, Inc. (TVTX)
50.65
-0.91
(-1.76%)
USD |
NASDAQ |
Nov 13, 16:00
50.70
+0.05
(+0.10%)
After-Hours: 07:24
Travere Therapeutics Price : 50.65 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 51.08 | 51.54 | 49.20 | 50.65 | 708198.0 |
| Nov 12, 2026 | 51.79 | 52.52 | 51.11 | 51.56 | 590308.0 |
| Nov 11, 2026 | 51.99 | 52.29 | 51.00 | 52.04 | 780550.0 |
| Nov 10, 2026 | 51.63 | 52.14 | 49.79 | 51.99 | 1.105M |
| Nov 09, 2026 | 50.34 | 51.74 | 49.89 | 51.63 | 2.068M |
| Nov 06, 2026 | 49.74 | 50.44 | 48.64 | 49.60 | 1.012M |
| Nov 05, 2026 | 51.91 | 52.42 | 48.59 | 48.87 | 2.193M |
| Nov 04, 2026 | 50.27 | 53.30 | 49.16 | 52.42 | 3.669M |
| Nov 03, 2026 | 46.52 | 49.68 | 44.73 | 49.41 | 9.080M |
| Nov 02, 2026 | 50.47 | 52.87 | 48.64 | 49.26 | 2.905M |
| Oct 30, 2026 | 50.01 | 52.66 | 49.71 | 50.39 | 1.141M |
| Oct 29, 2026 | 51.65 | 52.15 | 49.90 | 50.57 | 1.574M |
| Oct 28, 2026 | 50.20 | 50.91 | 49.52 | 50.84 | 1.573M |
| Oct 27, 2026 | 49.85 | 51.00 | 49.29 | 50.88 | 3.450M |
| Oct 26, 2026 | 50.52 | 51.32 | 49.24 | 49.97 | 3.342M |
| Oct 23, 2026 | 52.00 | 52.22 | 49.78 | 50.08 | 2.314M |
| Oct 22, 2026 | 52.34 | 53.12 | 51.25 | 52.43 | 1.774M |
| Oct 21, 2026 | 52.88 | 54.83 | 52.50 | 52.58 | 2.164M |
| Oct 20, 2026 | 50.43 | 52.70 | 50.40 | 52.30 | 2.058M |
| Oct 19, 2026 | 50.17 | 51.28 | 49.74 | 50.49 | 1.316M |
| Oct 16, 2026 | 52.56 | 52.56 | 49.46 | 49.60 | 1.828M |
| Oct 15, 2026 | 53.94 | 55.57 | 52.63 | 52.79 | 1.981M |
| Oct 14, 2026 | 51.61 | 53.94 | 51.53 | 53.27 | 2.061M |
| Oct 13, 2026 | 51.57 | 52.81 | 51.38 | 51.80 | 1.669M |
| Oct 12, 2026 | 51.74 | 53.35 | 51.74 | 52.02 | 1.424M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 538.60 |
| TG Therapeutics, Inc. | 64.51 |
| Viridian Therapeutics, Inc. | 30.87 |
| Arrowhead Pharmaceuticals, Inc. | 47.78 |
| BioMarin Pharmaceutical, Inc. | 57.23 |
Price Related Metrics
| PS Ratio | 7.202 |
| PEG Ratio | -0.5765 |
| Price to Book Value | 214.57 |
| Price to Free Cash Flow | 54.69 |
| Earnings Yield | -3.28% |
| Market Cap | 4.846B |
| PEGY Ratio | -0.5765 |